题名 | Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer |
作者 | |
通讯作者 | Wu, Zhiqiang |
发表日期 | 2023-08-01
|
DOI | |
发表期刊 | |
ISSN | 1590-1874
|
EISSN | 1590-3478
|
卷号 | 44期号:11 |
摘要 | Posterior reversible encephalopathy syndrome (PRES) is a rare, reversible neurological disease that is frequently associated with the use of targeted therapy agents. In this case study, we examine the development of posterior reversible encephalopathy syndrome (PRES) in a 44-year-old woman with metastatic colon cancer following 1 month of treatment with the vascular endothelial growth factor receptor (VEGFR) inhibitor, fruquintinib. The occurrence of PRES after 1 month of VEGFR inhibitor administration is a common phenomenon. However, it is noteworthy that this is the first reported case of PRES associated with fruquintinib. The patient's neurological function improved upon discontinuing the drug for a week, but worsening was observed following a lower-dose fruquintinib treatment. This patient's experience highlights the potential for neurological deterioration in those treated with fruquintinib, prompting physicians to consider the possibility of PRES. Notably, this may be the first reported case linking fruquintinib to the syndrome, underscoring the importance of recognizing the association between PRES and fruquintinib. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
WOS研究方向 | Neurosciences & Neurology
|
WOS类目 | Clinical Neurology
; Neurosciences
|
WOS记录号 | WOS:001049066000002
|
出版者 | |
ESI学科分类 | NEUROSCIENCE & BEHAVIOR
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:1
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/583024 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Wuhan Univ Sci & Technol, Xiaogan Hosp, Dept Neurol, Xiaogan, Hubei, Peoples R China 2.Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 1,Dept Neurol,Clin Med Coll 2, Shenzhen 518001, Guangdong, Peoples R China |
推荐引用方式 GB/T 7714 |
Wang, Lu,Zeng, Zhaohao,Wu, Zhiqiang. Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer[J]. NEUROLOGICAL SCIENCES,2023,44(11).
|
APA |
Wang, Lu,Zeng, Zhaohao,&Wu, Zhiqiang.(2023).Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer.NEUROLOGICAL SCIENCES,44(11).
|
MLA |
Wang, Lu,et al."Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer".NEUROLOGICAL SCIENCES 44.11(2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论